InvestorsObserver is giving Silverback Therapeutics Inc (SBTX) an Analyst Rating Rank of 5, meaning SBTX is ranked higher by analysts than 5% of stocks. The average price target for SBTX is $4.25 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating SBTX a Hold today. Find out what this means to you and get the rest of the rankings on SBTX!